FGEBM 003 – In Which We Entertain the Beneficial Effects of Baking Soda
In Which We Entertain the Beneficial Effects of Baking Soda EMCrit Project by Rory Spiegel .
Stories from Emcrit
Use this page to scan recent stories from Emcrit, see the themes that keep appearing, and jump into complete story briefs.
Recurring themes in this source.
EMNerdfgebmEMCritRACC-LitPULMCritpodcasts
Recent curated reads
EMCrit RACC Lit Review – September 2026
All the literature goodness for September 2026 EMCrit Project by Scott Weingart, MD FCCM .
PulmCrit: Myth-busting pulse dose steroid for non-CNS indications
Pulse-dose methylprednisolone is common across many medical fields (defined here as giving ≧500 mg methylprednisolone daily for ≧3 days). However, providing such a high dose of steroids may increase the risk of steroid-related complications (especially invasive fungal infections). What is the evidence behind this pract
The Case of the Obscured Bias
SCCM recently published updated guidelines on neuromuscular blockade in ARDS. The authors present five recommendations, the first being the most potentially influential on practice. “Paralyze patients with ARDS when their P/F ratio drops below 150 and they are persistently hypoxemic or fighting the ventilator.”[1] The
EMCrit 434 – Temporary Hemodialysis (HD) Catheters
Waiting for outside teams to place emergent dialysis lines directly harms critically ill patients requiring immediate RRT or exchange transfusions. In this episode, I break down the essential skill set for non-tunneled hemodialysis catheter insertion, covering line selection, site physiology, pre-dilation confirmation,
EMCrit 433 – HALO (High Acuity, Low Occurrence) Procedural Philosophy
I break down the distinction between institutional competence and operator-level systems competence for High-Acuity, Low-Occurrence (HALO) emergency procedures. The episode discusses recent literature on system vs. operator failure modes, introduces the "Recipe Method" for procedural self-mastery, and outlines a compre
The Tall-Tale Heart
It seems like every few years, someone tests whether further risk stratification in patients following a negative workup for acute coronary syndrome (ACS) provides a clinically meaningful benefit, and the answer has been remarkably consistent. Every few years, the answer is no. On this occasion, the TARGET-CTCA trial1,
You are caught up for now.
Read this source in the app
Open the app view when you want faster scanning, saved stories, and source-focused reading in one place.